drugset
drugset / Trial / NCT00409721

The Effect of Memantine on Functional Outcomes and Motor Neuron Degeneration in Amyotrophic Lateral Sclerosis (ALS)

NCT00409721 ↗

Phase 2 Completed 42 enrolled University of Alberta ALS Association · collab
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of the study is to investigate the effects of memantine in ALS patients using functional outcome measures.

Timeline

Start
2007-03
Primary completion
2010-12
Completion
2010-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Memantine Unknown — —

Indications

amyotrophic lateral sclerosis